Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis

Daniel R. Morales*, Tatiana Macfarlane, Thomas M. MacDonald, Jesper Hallas, Martin Thomsen Ernst, Ron M.C. Herings, Elisabeth Smits, Jetty A. Overbeek, Lyn Mitchell, Steven Morant, Isla Mackenzie, Alexander S.F. Doney, Chris Robertson, Marion Bennie, Li Wei, Lizzie Nicholson, Carole Morris, Robert W.F. Flynn

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences